Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Admission to trading of Transferable Securities

29th May 2026 15:49

RNS Number : 3044G
Santander UK Plc
29 May 2026
 

SANTANDER UK PLC

(LEI: PTCQB104N23FMNK2RZ28)

STRUCTURED NOTE AND CERTIFICATE PROGRAMME

 

NOTIFICATION OF ADMISSION TO TRADING OF TRANSFERABLE SECURITIES

 

The following transferrable securities issued by Santander UK plc (the Issuer) have today 29 May 2026 been admitted to trading on the main market of the London Stock Exchange plc:

 

(1)  Issue of £436,617 Preference Share-linked Autocallable Notes due 2032 (the Series 1322 Notes) (XS3326355578); and

(2)  Issue of £549,725 Preference Share-linked Autocallable Notes due 2032 (the Series 1323 Notes) (XS3326358671), and together with the Series 1322 Notes, the Notes).

 

The Notes are issued under the Issuer's Structured Note and Certificate programme pursuant to a Base Prospectus dated 13 March 2026, as supplemented from time to time (the Base Prospectus), read together with the Final Terms of the Notes dated 30 March 2026 (the Final Terms).

 

Full information on the Issuer and the offer of the Notes is only available on the basis of the Base Prospectus, read together with the Final Terms.

 

The Base Prospectus and the Final Terms have been published on the website of the London Stock Exchange.

 

 

For further information, please contact:

 

The Structured Notes Desk: [email protected]

Please note that the information contained in the Base Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus and/or the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and/or the Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus, and/or the Final Terms, you must ascertain from the Base Prospectus and/or the Final Terms whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The Final Terms referenced herein does not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act.

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ADMFLFSSETIAFIR

Related Shares:

Sant Uk.8fepf
FTSE 100 Latest
Value10,471.72
Change167.84